Previous 10 | Next 10 |
Novocure to report first quarter financial results on Thursday, April 30, 2020 Novocure (NASDAQ: NVCR) today provided an update on its response to the global COVID-19 pandemic and an initial evaluation of the impact the pandemic may have on Novocure’s general business operations...
Directive mandates reimbursement coverage of Tumor Treating Fields for patients with newly diagnosed glioblastoma by the compulsory health insurance system Novocure (NASDAQ: NVCR) today announced that the German Federal Joint Committee, or G-BA, has updated its directive for Contracted...
Shares of Novocure (NASDAQ: NVCR) , Insulet (NASDAQ: PODD) , and Dexcom (NASDAQ: DXCM) all rose by double digits in afternoon trading on Thursday. As of 3:15 p.m. EDT, these healthcare stocks were up 10%, 7%, and 10%, respectively. The major U.S. ...
Shares of ShockWave Medical (NASDAQ: SWAV) , Novocure (NASDAQ: NVCR) , and Guardant Health (NASDAQ: GH) all plunged on Monday. These healthcare stocks ended the trading session down 15%, 12%, and 17%, respectively. The Federal Open Market Committee, which i...
Data from study on Tumor Treating Fields in combination with anti-PD-1 therapy published in Cancer Immunology, Immunotherapy Novocure (NASDAQ: NVCR) announced today that preclinical data on Tumor Treating Fields in combination with anti-PD-1 therapy were published in the peer-reviewe...
Image source: The Motley Fool. NovoCure Limited (NASDAQ: NVCR) Q4 2019 Earnings Call Feb 27, 2020 , 1:30 p.m. ET Ashley Cordova -- Senior Vice President of Finance and Investor Relations Continue reading
In response to the reported fourth-quarter and full-year results, shares of NovoCure (NASDAQ: NVCR) , a high-growth medical device company that is focused on cancer, fell as much as 12% in early-morning trading on Thursday. The stock eventually recovered and was down about 2% as of 3:0...
NovoCure Limited (NVCR) Q4 2019 Earnings Conference Call February 27, 2020 8:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Finance & Investor Relations William Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Wilco Groenhuysen - C...
Healthcare Pulse Source: Bloomberg The fear of Coronavirus (Covid-19) has infected the stock market. The market's patience completely ran out this week as the Coronavirus news, which has continued to weigh heavily on the negative side, sent the market reeling in a feral pullback. Wha...
The following slide deck was published by NovoCure Limited in conjunction with their 2019 Q4 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-25 17:30:15 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q2 2024 Earnings Call Jul 25, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q2 2024 Earnings Call Transcript
Quarterly net revenues of $150 million, up 19% year-over-year, with 3,963 active patients on therapy as of June 30, 2024 Positive results from Phase 3 METIS trial in brain metastases from non-small cell lung cancer presented at ASCO 2024 Novocure (NASDAQ: NVCR) today reported fi...